Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan

BACKGROUND: There are many commercially available automated assays for assessing coronavirus disease 2019 (COVID-19) immune responses; however, owing to insufficient data, their validities remain unknown. Here, we examined antibody responses during acute-phase COVID-19 using four assays that detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibino, Makoto, Watanabe, Shigehiro, Tobe, Shunichi, Maeda, Kazunari, Horiuchi, Shigeto, Nishiguchi, Sho, Iwase, Akihiko, Uryu, Kiyoaki, Kobayashi, Shuzo, Kondo, Tetsuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639401/
https://www.ncbi.nlm.nih.gov/pubmed/34924308
http://dx.doi.org/10.1016/j.resinv.2021.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639401/
https://www.ncbi.nlm.nih.gov/pubmed/34924308
http://dx.doi.org/10.1016/j.resinv.2021.11.006

Ejemplares similares